Applicant, as named in the Orange Book

Rempex

Next listed expiry: Minocin on 16 Oct 2032. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Minocin NDA 050444 minocycline hydrochloride	minocycline hydrochloride	16 Oct 2032 patent	patent
Vabomere NDA 209776 meropenem; vaborbactam	meropenem; vaborbactam	6 Apr 2039 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.